GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

Publication | Open Access

DOI Full Paper Access

Citations

References

2019

Year

Francesca Bonifazi, Carlos Solano, Christine Wolschke, Mariarosaria Sessa, Francesca Patriarca, Francesco Zallio, Arnon Nagler, Carmine Selleri, Antonio M. Risitano, Giuseppe Messina,

The Lancet Haematology

Hematological MalignancyAcute LeukaemiaTransplantationMarrow TransplantationBone Marrow FailureGvhd ProphylaxisStem Cell TransplantationImmunologyHematologyHla-identical SiblingsBlood TransplantationImmunotherapyMedicineCell Transplantation